Aclaris Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
13,324.00
16,130.00
84,868.00
137,222.00
193,857.00
167,972
Total Accounts Receivable
-
-
-
-
481.00
4,861
Other Current Assets
62.00
204.00
1,656.00
1,334.00
5,883.00
5,875
Total Current Assets
13,386.00
16,334.00
86,524.00
138,556.00
200,221.00
179,499
Net Property, Plant & Equipment
19.00
515.00
360.00
481.00
2,159.00
4,280
Total Investments and Advances
802.00
518.00
7,170.00
36,912.00
14,997.00
-
Intangible Assets
-
-
-
-
25,853.00
91,455
Other Assets
-
10.00
22.00
136.00
279.00
332
Total Assets
14,207.00
17,377.00
94,076.00
176,085.00
292,492.00
275,566
Accounts Payable
353.00
1,263.00
-
-
7,822.00
Other Current Liabilities
14.00
188.00
1,555.00
6,223.00
4,940.00
Total Current Liabilities
367.00
1,451.00
1,555.00
6,223.00
12,762.00
Deferred Taxes
-
-
-
-
549.00
Other Liabilities
3.00
4.00
-
372.00
4,936.00
Total Liabilities
370.00
1,455.00
1,555.00
6,595.00
67,230.00
Common Equity (Total)
9,163.00
20,755.00
92,521.00
169,490.00
225,262.00
Total Shareholders' Equity
13,837.00
15,922.00
92,521.00
169,490.00
225,262.00
Total Equity
13,837.00
15,922.00
92,521.00
169,490.00
225,262.00
Liabilities & Shareholders' Equity
14,207.00
17,377.00
94,076.00
176,085.00
292,492.00
Preferred Stock (Carrying Value)
23,000.00
36,677.00
-
-
-
About Aclaris Therapeutics
View Profile
